These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 28583663)
1. In response to: Human papillomavirus screening for low and middle-income countries. Schiffman M Prev Med; 2017 Jul; 100():297-298. PubMed ID: 28583663 [No Abstract] [Full Text] [Related]
2. Human papillomavirus vaccination in Africa. Ouedraogo N; Müller O; Jahn A; Gerhardus A Lancet; 2011 Jul; 378(9788):315-6. PubMed ID: 21784261 [No Abstract] [Full Text] [Related]
4. Correspondence regarding Suba et al., human papillomavirus screening for low and middle-income countries. Castle PE Prev Med; 2017 Dec; 105():356. PubMed ID: 28939142 [No Abstract] [Full Text] [Related]
5. Correspondence regarding Castle., Human papillomavirus screening for low and middle-income countries. Suba EJ Prev Med; 2017 Dec; 105():357-358. PubMed ID: 28780060 [No Abstract] [Full Text] [Related]
6. HPV vaccine for primary prevention of cervical cancer in developing countries: the missing links. Sarin R J Cancer Res Ther; 2008; 4(3):105-6. PubMed ID: 18923200 [No Abstract] [Full Text] [Related]
7. Human papillomavirus, current vaccines, and cervical cancer prevention. Teitelman AM; Stringer M; Averbuch T; Witkoski A J Obstet Gynecol Neonatal Nurs; 2009; 38(1):69-80. PubMed ID: 19208050 [TBL] [Abstract][Full Text] [Related]
8. Prevention of HPV disease burden. Lehtinen M; Nieminen P; Apter D; Paavonen J Womens Health (Lond); 2014 Jul; 10(4):341-3. PubMed ID: 25259894 [No Abstract] [Full Text] [Related]
9. A model for the implementation of cervical cancer screening and human papillomavirus vaccination in the ED: a pilot study. Devine AS; Mason J; Rankins N; Favor TT; Baur V; Parker R; Baddorf S; McCarthy M; Ford L; Cunningham TD Am J Emerg Med; 2016 Mar; 34(3):648. PubMed ID: 26851060 [No Abstract] [Full Text] [Related]
10. HPV prevention: waiting for screening services. Finn A Lancet; 2010 May; 375(9727):1694. PubMed ID: 20472170 [No Abstract] [Full Text] [Related]
11. Human papillomavirus. Brody H Nature; 2012 Aug; 488(7413):S1. PubMed ID: 22932432 [No Abstract] [Full Text] [Related]
13. Editorial: Recent Advances in Molecular Detection of Human Papillomavirus and Cervical Cancer Screening. Poljak M; Ginocchio CC J Clin Virol; 2016 Mar; 76 Suppl 1():S1-S2. PubMed ID: 26597652 [No Abstract] [Full Text] [Related]
14. Comment on "New paradigm for prevention of cervical cancer" [Eur J Obstet Gynecol Reprod Biol 2007;130(1):25-9]. Mahajan NN; Gaikwad NL; Soni RN; Mahajan KN Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):140-1; author reply 141. PubMed ID: 17524549 [No Abstract] [Full Text] [Related]
15. Cervical cancer screening in low- and middle-income countries. Ditzian LR; David-West G; Maza M; Hartmann B; Shirazian T; Cremer M Mt Sinai J Med; 2011; 78(3):319-26. PubMed ID: 21598259 [TBL] [Abstract][Full Text] [Related]
16. Latin America. Price is the main barrier to wider use of papillomavirus vaccine. Kaiser J Science; 2008 May; 320(5878):860. PubMed ID: 18487164 [No Abstract] [Full Text] [Related]
17. Screening for cervical cancer: controversy and contention or thoughtful analysis. Frable WJ Cancer; 2007 Jun; 111(3):143-4. PubMed ID: 17487849 [No Abstract] [Full Text] [Related]
18. [Strategy for the prevention of papillomavirus related diseases. Substantiation of a programmatic decision in Chile]. Moreno G Rev Chilena Infectol; 2014 Apr; 31(2):204-6. PubMed ID: 24878909 [No Abstract] [Full Text] [Related]
19. [New guidelines in regard to cervical cancer screening]. Vargas-Hernández VM; Acosta-Altamirano G; Moreno-Eutimio MA; Vargas-Aguilar VM Cir Cir; 2014; 82(4):453-9. PubMed ID: 25167359 [TBL] [Abstract][Full Text] [Related]
20. Towards global prevention of human papillomavirus-induced cancer. Roden RB; Gravitt P; Wu TC Eur J Immunol; 2008 Feb; 38(2):323-6. PubMed ID: 18228245 [No Abstract] [Full Text] [Related] [Next] [New Search]